Study to Evaluate the Safety and Efficacy of VIRAZOLE ® in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19

Condition:   COVID19 Interventions:   Drug: 50 mg/mL Virazole;   Drug: 100 mg/mL Virazole Sponsor:   Bausch Health Americas, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials